ECMO program in regional hospital without cardiosurgery
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F27283933%3A_____%2F18%3A00005971" target="_blank" >RIV/27283933:_____/18:00005971 - isvavai.cz</a>
Výsledek na webu
<a href="http://journals.sagepub.com/doi/pdf/10.1177/0267659118767502" target="_blank" >http://journals.sagepub.com/doi/pdf/10.1177/0267659118767502</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1177/0267659118767502" target="_blank" >10.1177/0267659118767502</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
ECMO program in regional hospital without cardiosurgery
Popis výsledku v původním jazyce
Introduction: Extracorporeal membranous oxygenation (ECMO) is metod with rising usage by patients with cardiogenic shock or refractery cardiac arrest. We describe 18 month expiriences of ECMO program in regional hospital without cardiosurgery. Methods: Prospective registry of all patients treated with ECMO since April 2015. Results: We provided 15 connections (93,6% men, average age 61,3 /-8,1 years). Indications: 1x protected PCI of stem of left coronary artery, 7x cardiogenic shock with previous cardiac arrest, 3x refractery cardiac arrest, 3x cardiogenic shock without cardiac arrest and 1x refractery lung failure. Etiology: 4x pulmonary embolism, 6x myocardial infraction with ST elevation, 1x dilated cardiomyopathy, 1x precutaneous coronary intervention by high risk úatient, 1x aortic stenosis, 1x nonSTEMI a 1x respiratory failure. Cannulation were 100% successfull weaning was provided by9 (60%) of patients, average time on ECMO was 6.6 /-2.5 days. Only 2 patients were subsequently transfere to cardiosurgery (1x aortic valve substitution and 1x LVAD implantation). We observed 30-days outcome in good neurological condition (CPC 1 and 2) by 8 (53%) of patients. Hospital mortality was 47%. Refractery cardiac arrest had 100% mortality, cardiogenic shock 33% (the mortality was the same for both group-cardiogenic shock with or without cardiac arrest). Conclusion: We provided 15 ECMO implementation in 18 months from vital indication without any technical complications. Only 2 patients required subsequened cardiosurgery care. 30 days survival in good neurological outcome was 53%, succefull weaning 60%. Our experiences indicate feasibility of ECMO program in regional centers without cardiosurgery.
Název v anglickém jazyce
ECMO program in regional hospital without cardiosurgery
Popis výsledku anglicky
Introduction: Extracorporeal membranous oxygenation (ECMO) is metod with rising usage by patients with cardiogenic shock or refractery cardiac arrest. We describe 18 month expiriences of ECMO program in regional hospital without cardiosurgery. Methods: Prospective registry of all patients treated with ECMO since April 2015. Results: We provided 15 connections (93,6% men, average age 61,3 /-8,1 years). Indications: 1x protected PCI of stem of left coronary artery, 7x cardiogenic shock with previous cardiac arrest, 3x refractery cardiac arrest, 3x cardiogenic shock without cardiac arrest and 1x refractery lung failure. Etiology: 4x pulmonary embolism, 6x myocardial infraction with ST elevation, 1x dilated cardiomyopathy, 1x precutaneous coronary intervention by high risk úatient, 1x aortic stenosis, 1x nonSTEMI a 1x respiratory failure. Cannulation were 100% successfull weaning was provided by9 (60%) of patients, average time on ECMO was 6.6 /-2.5 days. Only 2 patients were subsequently transfere to cardiosurgery (1x aortic valve substitution and 1x LVAD implantation). We observed 30-days outcome in good neurological condition (CPC 1 and 2) by 8 (53%) of patients. Hospital mortality was 47%. Refractery cardiac arrest had 100% mortality, cardiogenic shock 33% (the mortality was the same for both group-cardiogenic shock with or without cardiac arrest). Conclusion: We provided 15 ECMO implementation in 18 months from vital indication without any technical complications. Only 2 patients required subsequened cardiosurgery care. 30 days survival in good neurological outcome was 53%, succefull weaning 60%. Our experiences indicate feasibility of ECMO program in regional centers without cardiosurgery.
Klasifikace
Druh
O - Ostatní výsledky
CEP obor
—
OECD FORD obor
30201 - Cardiac and Cardiovascular systems
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2018
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů